Research Highlights:

• New research indicates that cannabis use appears to be linked to an increased risk of cardiovascular disease, especially stroke.
• The findings are from an analysis of almost half a million U.S. adults who responded to telephone surveys for the Behavioral Risk Factor Surveillance System. This was limited to jurisdictions with available cannabis-use information between 2020 and 2024.
• The findings suggest considering cannabis use when assessing the risk of cardiovascular disease since its use is increasing. It is important to include this information in counseling patients about heart disease and stroke prevention, researchers said.
• Note: The study featured in this news release is a research abstract. Abstracts presented at the American Heart Association’s scientific meetings are not peer-reviewed, and the findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.

Embargoed until 4 a.m. CT/5 a.m. ET, Monday, Nov. 2, 2026

November 2, 2026 (NEWMEDIAWIRE) - DALLAS - Cannabis use, including marijuana, appears to be linked with increased cardiovascular risk, especially for stroke, making it an important consideration for heart disease and stroke prevention and counseling, according to independent, new preliminary research to be presented at the American Heart Association’s Scientific Sessions 2026. The meeting, Nov. 6-9, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science.

Regardless of the form (smoked or edible, etc.), cannabis use, which includes marijuana, was associated with the same outcome. From a scientific standpoint, cannabis is the plant, while marijuana is a common term for cannabis products that contain enough THC to produce psychoactive effects.

“Previous research has indicated that cannabis use is rapidly increasing in the United States, with 1 in 6 adults in 2024 reporting having used it within the last month, up from 1 in 10 in 2020 - a 51% increase,” said study author Aabha Divya, M.B.B.S., M.Ch., an assistant professor in the division of cardiothoracic surgery at the Tulane University School of Medicine in New Orleans.

Between 2016 and 2020, prior research found that cannabis use was linked to poor cardiovascular outcomes, and using cannabis more days per month was associated with an increased risk of poor cardiovascular outcomes.

“We wanted to expand on this earlier work because cannabis use has become increasingly common in the United States, as recreational legalization and commercial availability of various products with cannabis have also expanded. Previous studies have raised concerns about possible cardiovascular effects; however, the results have not been consistent,” Divya said.

For the current study, the researchers analyzed pooled data for almost half a million adults in the U.S. who responded to telephone interview questions about cannabis use as part of the Behavioral Risk Factor Surveillance System (BRFSS). This was limited to jurisdictions with available cannabis-use information between 2020 and 2024. Participants also reported if a health professional had ever told them they had cardiovascular disease - if they had experienced a heart attack or stroke or if they had been diagnosed with coronary heart disease.

What are the main findings?

• Compared with people who reported no cannabis use, those who reported using cannabis on 1 to 5 days per month had 23% higher odds of reporting a history of cardiovascular disease.
• Heavy cannabis users, defined as those who reported using it for 16 to 30 days per month, had 21% higher odds of reporting a history of cardiovascular disease.
• The strongest link between cannabis use and cardiovascular disease was with stroke. Reported low-frequency cannabis use was associated with 40% higher odds of stroke, and heavy use had 25% higher odds of stroke.
• Researchers did not see a statistically significant association between the reported frequency of cannabis use and heart attack.

“We were surprised to find that the link between cannabis use and cardiovascular disease was not straightforward. We expected that the chances of heart disease would gradually rise as people used cannabis more often, but that wasn’t the case. Both low-use and heavy-use groups had higher odds of developing heart disease,” Divya said.

“As cannabis use becomes more common, it is increasingly important that people and their healthcare professionals include it in conversations about cardiovascular health, just as they discuss tobacco, alcohol and other commonly used substances,” she added.

Robert L. Page II, Pharm.D., M.S.P.H., FAHA, chair of the writing group for the American Heart Association’s 2020 cannabis scientific statement, said, “Unfortunately, many patients who use cannabis may also smoke tobacco, which completely clouds the issue when addressing atherosclerotic cardiovascular disease risk. In patients who use both, cannabis has always been considered an innocent bystander; however, this is not the case. This is the second observational study to suggest that cannabis exposure (without tobacco smoking) may be a potential risk factor for developing cardiovascular disease. Overall, cannabis is beginning to emerge as a major contributor to premature heart disease in young and older adults, which can lead to serious cardiovascular events. To this end, clinicians should be addressing cannabis use with their patients as they would tobacco use when considering the risk of cardiovascular disease.” Page is also a professor in the department of clinical pharmacy and the department of physical medicine/rehabilitation at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado, and was not a part of this study.

What are the study details, background, design and limitations?

• The study included 442,906 U.S. adults (average age of 49 years; approximately half women) surveyed by telephone as part of the BRFSS.
• The study analyzed 2020-2024 BRFSS data from states that included the optional marijuana module in their telephone surveys, with 16-24 states participating each year. The cannabis questions were optional, and the analysis did not include all U.S. states.
• The survey asked about the number of days participants used cannabis (smoking, vaping or ingesting gummies or other cannabis-containing foods) in the previous month. Use was characterized as none; low frequency for 1-5 days in the past 30 days; moderate frequency for 6-15 days of the month; or heavy frequency for 16-30 days out of the previous month.
• Participants were also asked whether they had previously been diagnosed with a heart attack, heart disease, heart-related chest pain or stroke.
• The association between cannabis use and heart disease was calculated after adjusting for several heart disease risk factors, including demographics, tobacco smoking, alcohol use, obesity, diabetes, chronic kidney disease, physical inactivity, level of education and income.
• The study is limited by presenting associations from a single point in time, so it cannot prove that cannabis use causes heart disease. In addition, it relied on participants’ self-reported information about their cannabis use and heart-disease diagnoses (making them subject to potential errors in memory), and the study did not have any information about the potency of the cannabis product used or the amount consumed. People may also have reduced or stopped cannabis use after a diagnosis, and the no-recent-use group could include former users.

Co-authors, disclosures and funding sources are listed in the abstract.

Statements and conclusions of studies that are presented at the American Heart Association’s scientific meetings are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. Abstracts presented at the Association’s scientific meetings are not peer-reviewed, rather, they are curated by independent review panels and are considered based on the potential to add to the diversity of scientific issues and views discussed at the meeting. The findings are considered preliminary until published as a full manuscript in a peer-reviewed scientific journal.

The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.

Additional Resources:

• Multimedia, including video interview clips with American Heart Association volunteer expert, Robert L. Page II, Pharm.D., M.S.P.H., FAHA, is available on the right column of the release link.
• Spanish news release 
• Link to Abstract Poster Mo3041; and the American Heart Association’s Scientific Sessions 2026 Online Program Planner
• American Heart Association news release: Cannabis use linked to increase in heart attack and stroke risk (Feb. 2024)
• American Heart Association news release: Marijuana use linked with increased risk of heart attack, heart failure (Nov. 2023)
• About Scientific Sessions 2026
• For more news at the American Heart Association’s Scientific Sessions 2026, follow us on X @HeartNews, #ScientificSessions26

###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

For Media Inquiries and American Heart Association Expert Perspective: 214-706-1173

American Heart Association Communications & Media Relations in Dallas: ahacommunications@heart.org

Bridgette McNeill: Bridgette.McNeill@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org